Person

Sandra Leung

Formerly EVP, General Counsel, Bristol Myers Squibb

Current S&P 500 boards
0
Current roles
0
Open-market buys
$0
Open-market sales
$36.8M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

No current S&P 500 role.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

Sits alongside

People who currently share a board or management team with this person.

No current colleagues on record.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Jun 6, 2022BMYSale65,000$74.89$4.9M
Jul 30, 2021BMYSale29,390$68.04$2.0M
Aug 13, 2020BMYSale141,420$63.24$8.9M
Dec 4, 2017BMYSale156,582$63.37$9.9M
Mar 6, 2017BMYSale92,405$57.02$5.3M
May 6, 2016BMYSale72,544$70.39$5.1M
Feb 17, 2016BMYSale10,152$63.57$645K

SEC reporting-owner ID (CIK) 1199294 · all filings on EDGAR